Raney-nickel hydrogenolysis. Mechanism and pharmaceutical-chemical use
Hannig, M.; Moll, F.
Mitteilungen. Deutsche Pharmazeutische Gesellschaft 40(5): 149-160
1970
ISSN/ISBN: 0012-0561 PMID: 4916601 Document Number: 28693
Document emailed within 1 workday
Related Documents
Hładoń, T. 1981: Physico-chemical studies on adsorptive properties of pharmaceutic aids used in pharmaceutical technology. II. Mechanism of adsorption of sulfonamides on Veegum Acta Poloniae Pharmaceutica 38(2): 229-235Katz, S.A.; Bowen, H.J.; Comaish, J.S.; Samitz, M.H. 1975: Tissue nickel levels and nickel dermatitis. I. Nickel in hair British Journal of Dermatology 93(2): 187-190
Gawkrodger, D.J.; Shuttler, I.L.; Delves, H.T. 1988: Nickel dermatitis and diet: clinical improvement and a reduction in blood and urine nickel levels with a low-nickel diet Acta Dermato-Venereologica 68(5): 453-455
Lumb, G.; Sunderman, F.W. 1988: The mechanism of malignant tumor induction by nickel subsulfide Annals of Clinical and Laboratory Science 18(5): 353-366
Vajna, B.áz.; Nagy, Z.; Patyi, G.; Zsigmond, Z.; Antal, I.án.; Marosi, G.ör. 2009: Application possibilities of chemical imaging in pharmaceutical technology Acta Pharmaceutica Hungarica 79(3): 104-116
Hassler, E.; Lind, B.; Nilsson, B.; Piscator, M. 1983: Urinary and fecal elimination of nickel in relation to air-borne nickel in a battery factory Annals of Clinical and Laboratory Science 13(3): 217-224
Ciccarelli, R.B.; Wetterhahn, K.E. 1982: Nickel distribution and DNA lesions induced in rat tissues by the carcinogen nickel carbonate Cancer Research 42(9): 3544-3549
Gordon, B.M.; Moore, J.W. 2009: Nickel for your thoughts: Survey of the Congenital Cardiovascular Interventional Study Consortium (CCISC) for nickel allergy Journal of Invasive Cardiology 21(7): 326-329
Raithel, H.J.; Mayer, P.; Schaller, K.H.; Mohrmann, W.; Weltle, D.; Valentin, H. 1981: Exposure to nickel of workers in the glass industry. I. Analysis and quantification of external and internal nickel load Zentralblatt für Arbeitsmedizin, Arbeitsschutz, Prophylaxe und Ergonomie 31(8): 332-339
Hao, B.; Yang, X.-J.; Feng, Y.; Hong, Y.-L. 2014: Pharmaceutical research progress of rhynchophylla based on chemical stability Zhongguo Zhong Yao Za Zhi 39(23): 4532-4537
Bernacki, E.J.; Parsons, G.E.; Roy, B.R.; Mikac-Devic, M.; Kennedy, C.D.; Sunderman, F.W. 1978: Urine nickel concentrations in nickel-exposed workers Annals of Clinical and Laboratory Science 8(3): 184-189
Korolev, A.A.; Bogdanov, M.V.; Zaĭtsev, N.A.; Komiazhenkova, L.A. 1993: Rationale for hygienic standards in water of some chemical substances used by the pharmaceutical industry Gigiena i Sanitariia 11: 16-18
Szökó, E. 2002: Levetiracetam: a molecule with a novel mechanism of action in the pharmaceutical treatment of epilepsy Ideggyogyaszati Szemle 55(5-6): 195-196
Pashov, D. 1982: Tolerance and acute and subchronic toxicity of flavophospholipol from the Pharmaceutical Chemical Research Institute Veterinarno-Meditsinski Nauki 19(7): 73-80
Arndt, R.; Fröhlich, N.; Lehmann, E. 1984: Nickel burden in the grinding of nickel-containing alloys Zentralblatt für Arbeitsmedizin, Arbeitsschutz, Prophylaxe und Ergonomie 34(5): 138-143
Balbi, A.; Roma, G.; Di Braccio, M.; Ermili, A. 1978: Chemical and pharmaceutical research on pyran derivatives. X. Synthesis of 1-oxo-2-alkyl-3-dialkylamino-1H-naphtho[2,1b]pyrans Il Farmaco; Edizione Scientifica 33(11): 807-821
Căluşer, I.; Florescu, P. 1977: Myocardial necrosis through chemical-calcic mechanism Morphologie et Embryologie 23(4): 279-280
Bernadou, J.; Nguyen, M.; Meunier, B. 2001: The mechanism of action of isoniazid. a chemical model of activation Annales Pharmaceutiques Francaises 59(5): 331-337
Lu, X.Z. 1983: Immunological mechanism of a chemical antigen of Brucella M104 Zhonghua Liu Xing Bing Xue Za Zhi 4(3): 153-156
Kamiya, S. 1986: Synthesis of antitumor nitrosourea derivatives and chemical studies of their mechanism of action Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 104: 1-19